Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Cook

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmacoeconomics|January 27, 2005
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and NorwayJohn R Cook, Don Yin, Evo Alemao, et al.
Vaccine|August 26, 2011
Healthy-days time equivalents for outcomes of acute rotavirus infectionsA Brett Hauber, Robbin Itzler, F Reed Johnson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2008
Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries)Timo Vesikari, Robbin Itzler, David O Matson, et al.
Diabetes Care|March 1, 2003
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluationWilliam H Herman, Shahnaz Shahinfar, George W Carides, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudinePaul M Coplan, John R Cook, George W Carides, et al.
JAMA|October 17, 2002
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarctionElizabeth M Mahoney, Claudine T Jurkovitz, Haitao Chu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmacoeconomics|January 27, 2005
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and NorwayJohn R Cook, Don Yin, Evo Alemao, et al.
Vaccine|August 26, 2011
Healthy-days time equivalents for outcomes of acute rotavirus infectionsA Brett Hauber, Robbin Itzler, F Reed Johnson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2008
Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries)Timo Vesikari, Robbin Itzler, David O Matson, et al.
Diabetes Care|March 1, 2003
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluationWilliam H Herman, Shahnaz Shahinfar, George W Carides, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudinePaul M Coplan, John R Cook, George W Carides, et al.
JAMA|October 17, 2002
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarctionElizabeth M Mahoney, Claudine T Jurkovitz, Haitao Chu, et al.
Pageof 2